viernes, 13 de febrero de 2026

Trump administration is urged to use a federal law to authorize generic versions of GLP-1 drugs Public Citizen argued generics would yield savings, ease coverage restrictions, and expand access

https://www.statnews.com/pharmalot/2026/02/12/patents-obesity-novo-lilly-generics-wegovy-zepbound/ By Ed SilvermanFeb. 12, 2026 Pharmalot Columnist, Senior Writer

No hay comentarios: